Abstract
摘要
相似文献
1
Understanding generics.
J Drugs Dermatol. 2014 Jul;13(7):s75-6.
2
Generic drugs--safe, effective, and affordable.仿制药——安全、有效且价格亲民。
Dermatol Ther. 2009 May-Jun;22(3):229-40. doi: 10.1111/j.1529-8019.2009.01236.x.
3
Generic drugs in dermatology: part II.皮肤科的仿制药：第二部分。
J Am Acad Dermatol. 2012 Mar;66(3):353.e1-15; quiz 367-8. doi: 10.1016/j.jaad.2011.11.945.
4
The relationship between the number of available therapeutic options and government payer (medicare part D) spending on topical drug products.可供选择的治疗方案数量与政府支付者（医疗保险部分 D）在局部药物产品上的支出之间的关系。
Arch Dermatol Res. 2020 Oct;312(8):559-565. doi: 10.1007/s00403-020-02042-9. Epub 2020 Feb 13.
5
Dissecting drug pricing: Supply chain, market, and nonmarket trends impacting clinical dermatology.剖析药品定价：影响临床皮肤科的供应链、市场及非市场趋势
J Am Acad Dermatol. 2020 Aug;83(2):691-699. doi: 10.1016/j.jaad.2020.04.063. Epub 2020 Apr 21.
6
Association Between Market Competition and Prices of Generic Topical Dermatology Drugs.市场竞争与皮肤科外用药品通用名药物价格的关联。
JAMA Dermatol. 2018 Dec 1;154(12):1441-1446. doi: 10.1001/jamadermatol.2018.3798.
7
Variation in the Cost of Generic Topical Corticosteroids.普通外用皮质类固醇药物成本的差异。
JAMA Dermatol. 2015 Nov;151(11):1255-6. doi: 10.1001/jamadermatol.2015.2394.
8
Generic drugs in dermatology: part I.皮肤科的仿制药：第 I 部分。
J Am Acad Dermatol. 2012 Mar;66(3):343.e1-8; quiz 351-2. doi: 10.1016/j.jaad.2011.11.944.
9
Brand name versus generic drugs: the ethical quandary in caring for our sophisticated patients while trying to reduce health-care costs: facts and controversies.品牌药与仿制药：在关注我们的高需求患者的同时又试图降低医疗成本时所面临的伦理困境：事实与争议。
Clin Dermatol. 2013 Nov-Dec;31(6):772-6. doi: 10.1016/j.clindermatol.2013.05.015.
10
Rising drug costs: the impact on dermatology.不断上涨的药品成本：对皮肤科的影响。
Skin Therapy Lett. 2000;5(4):1-2,5.
Zotero 插件